APA (7th ed.) Citation

Kakkar, A., Doval, D., Fareed, J., Kerr, D., Maganji, J., & Mueller, I. (2010). RATIONALE AND DESIGN OF THE GASTRANOX TRIAL ON A LOW-MOLECULAR-WEIGHT HEPARIN [LMWH], ENOXAPARIN, WITH CHEMOTHERAPY VS. CHEMOTHERAPY ALONE IN INOPERABLE GASTRIC AND GASTRO-OESOPHAGEAL CANCER.

Chicago Style (17th ed.) Citation

Kakkar, A., D. Doval, J. Fareed, D. Kerr, J. Maganji, and I. Mueller. RATIONALE AND DESIGN OF THE GASTRANOX TRIAL ON A LOW-MOLECULAR-WEIGHT HEPARIN [LMWH], ENOXAPARIN, WITH CHEMOTHERAPY VS. CHEMOTHERAPY ALONE IN INOPERABLE GASTRIC AND GASTRO-OESOPHAGEAL CANCER. 2010.

MLA (9th ed.) Citation

Kakkar, A., et al. RATIONALE AND DESIGN OF THE GASTRANOX TRIAL ON A LOW-MOLECULAR-WEIGHT HEPARIN [LMWH], ENOXAPARIN, WITH CHEMOTHERAPY VS. CHEMOTHERAPY ALONE IN INOPERABLE GASTRIC AND GASTRO-OESOPHAGEAL CANCER. 2010.